ACH-0144471
Showing 1 - 25 of 88
Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Danicopan)
Completed
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
-
Florence, Italy
- +4 more
May 31, 2022
C3 Glomerulopathy, C3 Glomerulonephritis, Dense Deposit Disease Trial in United Kingdom, United States (Danicopan, Placebo)
Healthy Trial in Tempe (Danicopan: Powder-In-Capsule 1, Danicopan: Powder-In-Capsule 2, Danicopan: Tablet)
Completed
- Healthy
- Danicopan: Powder-In-Capsule 1
- +2 more
-
Tempe, ArizonaClinical Trial Site
Apr 8, 2022
C3 Glomerulonephritis, C3 Glomerulopathy, Immune Complex Membranoproliferative Glomerulonephritis Trial in Worldwide (Danicopan)
Terminated
- C3 Glomerulonephritis
- +4 more
-
Birmingham, Alabama
- +12 more
Aug 9, 2022
Healthy Trial in Ruddington (Danicopan Modified Release Prototype 1, Danicopan Modified Release Prototype 2, Danicopan Modified
Completed
- Healthy
- Danicopan Modified Release Prototype 1
- +2 more
-
Ruddington, Nottingham, United KingdomClinical Trial Site
Aug 16, 2021
C3 Glomerulonephritis, Dense Deposit Disease, C3 Glomerulopathy Trial in Melbourne, Antwerpen, Leiden (Danicopan)
Completed
- C3 Glomerulonephritis
- +4 more
-
Melbourne, Australia
- +2 more
Oct 7, 2021
Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Italy, United Kingdom, United States (Danicopan, Eculizumab)
Active, not recruiting
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
-
Baltimore, Maryland
- +4 more
Aug 15, 2022
Healthy Trial in Auckland (Danicopan - Tablet, Danicopan - Softgel, Danicopan - LFC)
Completed
- Healthy
- Danicopan - Tablet
- +2 more
-
Auckland, New ZealandClinical Trial Site
Jun 21, 2021
C3 Glomerulonephritis, C3 Glomerulopathy, Immune Complex Membranoproliferative Glomerulonephritis Trial in Ranica (Non
Completed
- C3 Glomerulonephritis
- +4 more
- Non contrast-enhanced magnetic resonance imaging
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Dac
Nov 24, 2021
Angina Pectoris, Variant, Angina Pectoris; Spasm-Induced, Angina Pectoris With Normal Coronary Arteriogram Trial in Antwerp
Recruiting
- Angina Pectoris, Variant
- +2 more
- Acetylcholine rechallenge
-
Antwerp, BelgiumUniversity Hospital Antwerp
Jan 17, 2023
Healthy Volunteers Trial in Melbourne (ACH-000029, Placebo)
Terminated
- Healthy Volunteers
- ACH-000029
- Placebo
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Jan 30, 2023
Children With Achondroplasia (ACH)
Recruiting
- Achondroplasia
-
Oakland, California
- +19 more
Apr 6, 2022
Achondroplasia Trial (Navepegritide, Placebo for Navepegritide)
Not yet recruiting
- Achondroplasia
- Navepegritide
- Placebo for Navepegritide
- (no location specified)
Oct 6, 2023